Rallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement – Business Wire

Rallybio Corporation and Avenzo Therapeutics Announce combination pact to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement  Business Wire

Source: news.google.com